$186.11
0.26% day before yesterday
NYSE, May 30, 10:12 pm CET
ISIN
US00287Y1091
Symbol
ABBV
Sector
Industry

AbbVie Stock price

$186.11
-8.99 4.61% 1M
+4.34 2.39% 6M
+8.41 4.73% YTD
+29.80 19.06% 1Y
+36.11 24.07% 3Y
+95.41 105.19% 5Y
+119.18 178.07% 10Y
NYSE, Closing price Fri, May 30 2025
+0.49 0.26%
ISIN
US00287Y1091
Symbol
ABBV
Sector
Industry

Key metrics

Market capitalization $328.75b
Enterprise Value $393.46b
P/E (TTM) P/E ratio 79.20
EV/FCF (TTM) EV/FCF 25.57
EV/Sales (TTM) EV/Sales 6.86
P/S ratio (TTM) P/S ratio 5.73
P/B ratio (TTM) P/B ratio 231.51
Dividend yield 3.38%
Last dividend (FY24) $6.29
Revenue growth (TTM) Revenue growth 5.45%
Revenue (TTM) Revenue $57.37b
EBIT (operating result TTM) EBIT $17.46b
Free Cash Flow (TTM) Free Cash Flow $15.39b
Cash position $5.18b
EPS (TTM) EPS $2.35
P/E forward 27.94
P/S forward 5.49
EV/Sales forward 6.57
Short interest 1.13%
Show more

Is AbbVie a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

AbbVie Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a AbbVie forecast:

18x Buy
60%
11x Hold
37%
1x Sell
3%

Analyst Opinions

30 Analysts have issued a AbbVie forecast:

Buy
60%
Hold
37%
Sell
3%

Financial data from AbbVie

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
57,367 57,367
5% 5%
100%
- Direct Costs 16,812 16,812
8% 8%
29%
40,555 40,555
12% 12%
71%
- Selling and Administrative Expenses 14,686 14,686
13% 13%
26%
- Research and Development Expense 8,419 8,419
15% 15%
15%
25,808 25,808
5% 5%
45%
- Depreciation and Amortization 8,351 8,351
3% 3%
15%
EBIT (Operating Income) EBIT 17,457 17,457
9% 9%
30%
Net Profit 4,155 4,155
30% 30%
7%

In millions USD.

Don't miss a Thing! We will send you all news about AbbVie directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AbbVie Stock News

Neutral
PRNewsWire
one day ago
Chicago-based institutions aim to create greater awareness for cancer advocacy and to support non-profit cancer organizations NORTH CHICAGO, Ill. , May 30, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced a multi-year partnership with the Chicago Cubs to support people living with cancer through a campaign called "Striking Out Cancer" which starts today when the Chicago Cubs play the Cincinna...
Positive
Seeking Alpha
3 days ago
Money market funds are booming with $7.2 trillion in assets, offering attractive short-term yields, but rising fees and competition could shake things up. I believe we're nearing a turning point: lower rates may push massive capital into dividend stocks, boosting prices and driving down future yields. In the second half of the article, I highlight three high-quality dividend stocks I believe co...
Neutral
Business Wire
4 days ago
NASHVILLE, Tenn.--(BUSINESS WIRE)--Today, Sarah Cannon Research Institute (SCRI), one of the world's leading oncology research organizations conducting community-based clinical trials, announced a strategic alliance with AbbVie. The alliance aims to accelerate the development of innovative therapies for patients with cancer through collaborative scientific engagement and operational synergies t...
More AbbVie News

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Head office United States
CEO Robert Michael
Employees 55,000
Founded 2011
Website www.abbvie.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today